Micromune Therapeutics
PrivateLast Round
Grant
Dec 23, 2024
Total Funding Raised
$2.81M
Company Overview
Micromune Therapeutics operates in Healthcare & Life Sciences and is based in Brisbane, Queensland. Its latest recorded funding round was a Grant round in December 2024.
Micromune Therapeutics is a biotechnology company developing a small molecule therapeutic for inflammatory bowel disease (IBD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Micromune Therapeutics Comparables
Compare Micromune Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vedanta Biosciences | 77% | |
| SFA Therapeutics | 77% | |
| Enterome | 76% |
For institutional investors. Book with your work email.
Micromune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 23, 2024 | ||||
| Grant | May 24, 2023 |
For institutional investors. Book with your work email.
Micromune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 23, 2024
Secured $2.48M in grant funding from CUREator.
For institutional investors. Book with your work email.
Micromune Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Micromune Therapeutics's valuation, stock price, and market status.
Is Micromune Therapeutics a public or private company?
Micromune Therapeutics is a private company.
What is the current stock price of Micromune Therapeutics?
Micromune Therapeutics is a private company, so its shares have no public market price. Caplight tracks Micromune Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Micromune Therapeutics worth (valuation)?
Valuation information for Micromune Therapeutics is not publicly available.
Can I buy Micromune Therapeutics stock?
Micromune Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Micromune Therapeutics's last funding round?
Micromune Therapeutics's most recent funding round was Grant on December 23, 2024.
Who are the main investors in Micromune Therapeutics?
Key investors in Micromune Therapeutics include CUREator.
Will Micromune Therapeutics IPO soon?
No public IPO plans have been announced for Micromune Therapeutics.
How can I track Micromune Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Micromune Therapeutics's shares on secondary markets.